Meet the team
Prof Nick Sevdalis
Nick Sevdalis is an academic Professor at King’s College London, where he has focused his efforts on clinical ‘implementation science’ – the science of accelerating the translation of evidence-based principles into routine care. Nick’s psychology background allows him to understand and analyse the barriers to behavioural change in doctors, teams and organisations and identify and overcome these barriers. At the same time, he is leading efforts to increase capability within the NHS to accelerate uptake of good clinical practices.
Mr James Green
James Green is a Consultant Urological Surgeon specialising in Cancer and Children and has published many papers on cancer care delivery and treatment. He is particularly interested in how safety and the care for patients can be improved by better team working. He has been encouraging surgical teams in his own unit to learn the tools to self-appraise, develop and improve services, in order to decrease the risk to patients during their care. This work led to national audits that have identified issues nationwide and to improvements in care. James will provide clinical and urological education leadership and liaison with programme directors.
Dr Zarnie Khadjesari
Zarnie Khadjesari is a senior postdoctoral fellow at the Centre for Implementation Science. Her three year fellowship, awarded by King’s Improvement Science, focusses on the identification and validation of implementation outcome measures suitable for use in physical healthcare settings. Zarnie’s background is in health services research. She has experience of leading qualitative and quantitative research and will provide methodological support to the project.
Ms. Elena Pallari
Elena Pallari joined the Centre for Implementation Science, as a research assistant on the development and evaluation of a quality improvement training programme for urology trainees. She previously held positions on a wide range of multidisciplinary projects from the conduct to evaluation and evidence-synthesis of clinical trials at the University College London Medical School, the Brunel Institute of Bioengineering and Imperial College London Business School. She is also affiliated with the King’s Institute of Cancer Policy.